The Nonstructural NS1 Protein of Influenza Viruses Modulates


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
01 04 2019
Historique:
received: 06 12 2018
accepted: 04 01 2019
pubmed: 18 1 2019
medline: 19 11 2019
entrez: 18 1 2019
Statut: epublish

Résumé

Influenza A viruses (IAV) are known to modulate and "hijack" several cellular host mechanisms, including gene splicing and RNA maturation machineries. These modulations alter host cellular responses and enable an optimal expression of viral products throughout infection. The interplay between the host protein p53 and IAV, in particular through the viral nonstructural protein NS1, has been shown to be supportive for IAV replication. However, it remains unknown whether alternatively spliced isoforms of p53, known to modulate p53 transcriptional activity, are affected by IAV infection and contribute to IAV replication. Using a

Identifiants

pubmed: 30651364
pii: JVI.02168-18
doi: 10.1128/JVI.02168-18
pmc: PMC6430556
pii:
doi:

Substances chimiques

INS1 protein, influenza virus 0
TP53 protein, human 0
Tumor Suppressor Protein p53 0
Viral Nonstructural Proteins 0
mRNA Cleavage and Polyadenylation Factors 0
Interferons 9008-11-1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

Nat Rev Mol Cell Biol. 2015 Jul;16(7):393-405
pubmed: 26122615
J Mol Biol. 2017 Oct 27;429(21):3334-3352
pubmed: 28433538
J Virol. 2010 Jul;84(14):6909-22
pubmed: 20444891
BMC Med Genomics. 2015 Aug 18;8:52
pubmed: 26282854
J Biol Chem. 2012 May 25;287(22):18366-75
pubmed: 22474335
Lancet. 2017 Aug 12;390(10095):697-708
pubmed: 28302313
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):1954-9
pubmed: 20133840
Cell. 1995 Jan 27;80(2):293-9
pubmed: 7834749
Cell Microbiol. 2007 Apr;9(4):930-8
pubmed: 17140406
J Virol. 2005 Jul;79(14):8802-11
pubmed: 15994774
Mol Cell. 1998 Jun;1(7):991-1000
pubmed: 9651582
J Virol. 2012 Aug;86(16):8452-60
pubmed: 22647703
Genes Dev. 1997 Jul 1;11(13):1703-16
pubmed: 9224719
PLoS Pathog. 2013;9(4):e1003246
pubmed: 23592981
Nature. 2010 Feb 11;463(7282):818-22
pubmed: 20081832
Virol J. 2011 Jun 08;8:285
pubmed: 21651802
Nature. 2003 Jul 31;424(6948):516-23
pubmed: 12872134
J Virol. 2013 Mar;87(5):2430-40
pubmed: 23255794
J Virol. 2017 Feb 14;91(5):
pubmed: 28003482
J Virol. 2017 Jul 12;91(15):
pubmed: 28515301
Cold Spring Harb Perspect Med. 2016 Aug 01;6(8):
pubmed: 26801896
J Gen Virol. 2008 Oct;89(Pt 10):2359-2376
pubmed: 18796704
Genom Data. 2015 Oct 03;6:217-21
pubmed: 26697379
Cell Death Differ. 2014 Sep;21(9):1377-87
pubmed: 24926616
Virol J. 2013 Jul 25;10:243
pubmed: 23886034
Biochem Biophys Res Commun. 2010 Apr 23;395(1):141-5
pubmed: 20361939
J Virol. 2007 Jan;81(2):514-24
pubmed: 17079289
Cell Host Microbe. 2010 Jun 25;7(6):427-39
pubmed: 20542247
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13093-8
pubmed: 18725644
Nat Microbiol. 2016 May 27;1(7):16069
pubmed: 27572970
Virology. 2003 Mar 15;307(2):386-95
pubmed: 12667806
mBio. 2014 May 13;5(3):e00070-14
pubmed: 24825008
Influenza Other Respir Viruses. 2011 May;5(3):157-66
pubmed: 21477134
Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):E3840-8
pubmed: 24043788
Cold Spring Harb Perspect Biol. 2010 Dec;2(12):a000893
pubmed: 20463001
Rev Med Virol. 2011 Sep;21(5):285-300
pubmed: 21726011
EMBO J. 1993 Feb;12(2):585-94
pubmed: 8440247
Virology. 2017 Aug;508:170-179
pubmed: 28554059
Curr Top Microbiol Immunol. 2015;386:73-107
pubmed: 25007846
J Virol. 2014 Oct;88(20):12146-51
pubmed: 25078692
Oncogene. 2013 Jan 3;32(1):1-14
pubmed: 22349816
J Virol. 1995 Apr;69(4):2427-33
pubmed: 7884890
J Gen Virol. 1992 Dec;73 ( Pt 12):3325-9
pubmed: 1469370
J Gen Virol. 2014 Dec;95(Pt 12):2594-2611
pubmed: 25182164
Virology. 2010 Sep 1;404(2):215-24
pubmed: 20627352
FEBS Lett. 2013 Sep 17;587(18):2965-71
pubmed: 23954291
Cell Death Dis. 2015 May 21;6:e1768
pubmed: 25996295
Cold Spring Harb Perspect Biol. 2010 Mar;2(3):a000927
pubmed: 20300206
Cell. 1993 Nov 19;75(4):817-25
pubmed: 8242752
Nature. 2010 Feb 11;463(7282):813-7
pubmed: 20027183
Wiley Interdiscip Rev RNA. 2011 Jul-Aug;2(4):459-70
pubmed: 21957037
Nat Rev Immunol. 2016 Dec;16(12):741-750
pubmed: 27667712
Am J Respir Cell Mol Biol. 2007 Mar;36(3):263-9
pubmed: 17053203
Genes Dev. 2005 Sep 15;19(18):2122-37
pubmed: 16131611
Oncogene. 1993 Dec;8(12):3411-6
pubmed: 8247544
Virology. 2012 Oct 10;432(1):204-18
pubmed: 22770924
Curr Opin Virol. 2015 Oct;14:71-8
pubmed: 26364134
Cell Res. 2009 Feb;19(2):187-95
pubmed: 18813227
J Immunol. 2011 Dec 15;187(12):6428-36
pubmed: 22105999
RNA Biol. 2016;13(3):259-64
pubmed: 26891005
Curr Opin Virol. 2015 Jun;12:1-6
pubmed: 25638592
Rev Med Virol. 2013 Jul;23(4):213-20
pubmed: 23255396

Auteurs

Julia Dubois (J)

CIRI, Centre International de Recherche en Infectiologie, (Team VirPath ), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.
Centre de Recherche en Infectiologie, Centre Hospitalier Universitaire de Québec and Université Laval, Québec, Canada.

Aurélien Traversier (A)

CIRI, Centre International de Recherche en Infectiologie, (Team VirPath ), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.

Thomas Julien (T)

CIRI, Centre International de Recherche en Infectiologie, (Team VirPath ), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.

Blandine Padey (B)

CIRI, Centre International de Recherche en Infectiologie, (Team VirPath ), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.

Bruno Lina (B)

CIRI, Centre International de Recherche en Infectiologie, (Team VirPath ), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.
Laboratoire de Virologie, Centre National de Référence des Virus Influenza, Institut des Agents Infectieux, Groupement Hospitalier Nord, Hospices Civils de Lyon, Lyon, France.

Jean-Christophe Bourdon (JC)

Division of Cancer Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom.

Virginie Marcel (V)

INSERM U1052, CNRS UMR5286, Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.
Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France.

Guy Boivin (G)

Centre de Recherche en Infectiologie, Centre Hospitalier Universitaire de Québec and Université Laval, Québec, Canada.

Manuel Rosa-Calatrava (M)

CIRI, Centre International de Recherche en Infectiologie, (Team VirPath ), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.

Olivier Terrier (O)

CIRI, Centre International de Recherche en Infectiologie, (Team VirPath ), Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France olivier.terrier@univ-lyon1.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH